pharma · Gastroesophageal Reflux · Migraine · ADXN
Addex Therapeutics
Addex Therapeutics patent portfolio — 40 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- GENEVA, V8, CH
- Founded
- 2002
- Employees
- 21
- Programs
- 6
- Drugs
- 3
- Patents
- 40
Addex Therapeutics patents
40 pharmaceutical patents indexed for Addex Therapeutics. 1 expire within 24 months.
Addex Therapeutics has 40 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11071729
1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones
granted -
US 10071095
1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders
granted -
US 9938270
Mono-phosphate salt of 6-fluoro-2-[4-(pyridin-2-yl)but-3-yn-1-yl]imidazo[1,2A]pyridine (dipraglurant) and polymorphs thereof as negative allosteric modulator of MGLU5 receptor
granted -
US 9765091
Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors
granted -
US 9737533
1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
granted -
US 9266834
1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
granted -
US 9226930
1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
granted -
US 9132122
1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones
granted -
US 9114138
1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
granted -
US 9085577
7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
granted -
US 9073907
Thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
granted -
US 9067891
1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors
granted -
US 8946205
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
granted -
US 8937060
1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
granted -
US 8906939
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
granted -
US 8883826
Alkynyl derivatives as modulators of metabotropic glutamate receptors
granted -
US 8841323
1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
granted -
US 8785486
Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
granted -
US 8779129
Triazinedione derivatives as GABAB receptor modulators
granted -
US 8748621
1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
granted -
US 8722894
1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
granted -
US 8716480
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
granted -
US 8697744
Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric modulators of metabotropic glutamate receptors
granted -
US 8697689
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
granted -
US 8691813
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
granted -
US 8691849
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
granted -
US 8674106
Alkynyl derivatives as modulators of metabotropic glutamate receptors
granted -
US 8604033
Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors
granted -
US 8524718
Heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
granted -
US 8524726
Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
granted -
US 8513252
Pyrazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
granted -
US 8399493
Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
granted -
US 8344138
Triazinedione derivatives as GABAB receptor modulators
granted -
US 8299101
1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mGluR2-receptor modulators
granted -
US 8252937
1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
granted -
US 8163775
Allosteric modulators of metabotropic glutamate receptors
granted -
US 8101637
Alkynyl derivatives as modulators of metatropic glutamate receptors
granted -
US 8030331
Allosteric modulators of metabotropic glutamate receptors
granted -
US 7834035
Allosteric modulators of metabotropic glutamate receptors
granted -
US 7205411
Aminopyridine derivatives as mGluR5 antagonists
granted
Frequently asked questions
How many patents does Addex Therapeutics have?
40 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Addex Therapeutics patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.